合成生物学在新冠病毒广谱疫苗研发中的应用
袁为锋， 赵永亮， 吴芷萱， 徐可 - 合成生物学, 2024 - synbioj.cip.com.cn
新型冠状病毒(SARS-CoV-2) 自2019 年底引发疫情至今, 已经变异出Alpha, Beta, Delta
和Omicron 等不同谱系. 传统疫苗的抗原序列来源于某一自然分离株的原始序列 …
和Omicron 等不同谱系. 传统疫苗的抗原序列来源于某一自然分离株的原始序列 …
Applications of synthetic biology in the development of SARS-CoV-2 broad-spectrum vaccines
Y Weifeng, Z Yongliang, WU Zhixuan… - Synthetic Biology …, 2024 - synbioj.cip.com.cn
Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at
the end of 2019, it has evolved into different lineages, including Alpha, Beta, Delta, and …
the end of 2019, it has evolved into different lineages, including Alpha, Beta, Delta, and …
合成生物学与病毒疫苗研发
申赵铃， 吴艳玲， 应天雷 - 合成生物学, 2023 - synbioj.cip.com.cn
病毒所致的传染性疾病严重危害公共卫生安全, 给全球人类健康与经济发展带来了巨大的威胁.
疫苗是防治传染性疾病传播的一个关键且有效的手段, 包括全病毒疫苗, 亚单位疫苗 …
疫苗是防治传染性疾病传播的一个关键且有效的手段, 包括全病毒疫苗, 亚单位疫苗 …
抗新型冠状病毒单克隆中和抗体药物研发进展*
史瑞， 严景华 - 中国生物工程杂志, 2021 - manu60.magtech.com.cn
随着新型冠状病毒肺炎(COVID-19) 疫情在全球的不断蔓延, 开发有效的治疗药物迫在眉睫.
中和抗体作为最有希望的新型冠状病毒特异性治疗药物, 已经在临床研究中展现很好的治疗效果 …
中和抗体作为最有希望的新型冠状病毒特异性治疗药物, 已经在临床研究中展现很好的治疗效果 …
Race for a coronavirus vaccine: thanks in part to institutional support, CanSino biologics, Moderna therapeutics, and other developers are exploring diverse …
D Ricks - Genetic Engineering & Biotechnology News, 2020 - liebertpub.com
Vaccine developers are fast-tracking new constructs of various kinds—traditional vaccines,
RNA vaccines, DNA vaccines, and others—in hopes of catching up with COVID-19, the …
RNA vaccines, DNA vaccines, and others—in hopes of catching up with COVID-19, the …
新冠病毒抗体药物研发进展及展望分析
武瑞君， 李治非， 张鑫， 濮润， 敖翼… - 中国生物工程 …, 2020 - manu60.magtech.com.cn
抗体药物以其独特的作用机制和靶向性强, 特异性好等优点, 在恶性肿瘤, 自身免疫性疾病,
感染类疾病的诊断和治疗中发挥着越来越重要的作用, 成为国际创新药物研发的热点 …
感染类疾病的诊断和治疗中发挥着越来越重要的作用, 成为国际创新药物研发的热点 …
[HTML][HTML] Progress and current situation of sars-cov-2 subunit vaccine development
Y YANG, Q ZHANG, K MEI - China Biotechnology, 2022 - manu60.magtech.com.cn
Since the outbreak of novel coronavirus disease in late 2019, it has been a global public
safety emergency to efficiently prevent and control the epidemic. Vaccine is one of the …
safety emergency to efficiently prevent and control the epidemic. Vaccine is one of the …
[HTML][HTML] An overview of current COVID-19 vaccine platforms
A Nagy, B Alhatlani - Computational and structural biotechnology journal, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic that emerged in December 2019 in Wuhan …
coronavirus disease 2019 (COVID-19) pandemic that emerged in December 2019 in Wuhan …
[HTML][HTML] Progress and concept for COVID‐19 vaccine development
SC Wu - Biotechnology journal, 2020 - ncbi.nlm.nih.gov
The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
previously known by the provisional name 2019 novel coronavirus (2019-nCoV), in the city …
previously known by the provisional name 2019 novel coronavirus (2019-nCoV), in the city …
新冠肺炎疫苗的研究现状及面临的挑战
温亚亚， 宋丽， 汪巧菊， 潘志明， 焦新安 - 生物技术通报, 2022 - biotech.aiijournal.com
2019 年底爆发的新型冠状病毒肺炎(COVID-19) 造成了全球范围内的社会和经济混乱,
严重威胁着人类生命健康. 随着世界各国在新冠肺炎疫苗开发上的不断努力 …
严重威胁着人类生命健康. 随着世界各国在新冠肺炎疫苗开发上的不断努力 …